On Wednesday, Shares of Apple Inc. (NASDAQ:AAPL), added 0.89% and closed at $117.34 in the last trading session. The last trading range of the stock ranges between $116.75 and $117.98. The company’s Market capitalization is $633.64 Billion with the total Outstanding Shares of 5.39 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $89.47 and reached to max level of $123.82. Attorneys from Dallas’ Caldwell Cassady & Curry have won another multimillion-dollar patent infringement award for Nevada-based VirnetX Holding Corp. (NYSE MKT: VHC) against technology giant Apple Inc. (AAPL) based on an East Texas jury’s finding that Apple owes more than $302 million in royalties for infringing internet security patents owned by VirnetX.
Jurors in the Tyler, Texas, courtroom of Judge Robert W. Schroeder III delivered the verdict in favor of VirnetX on Sept. 30 after one week of trial. The case is VirnetX Inc., et al. v. Apple Inc., No. 6:10-CV-417, in the U.S. District Court for the Eastern District of Texas.
Caldwell Cassady & Curry name principals Bradley W. Caldwell, Jason D. Cassady and J. Austin Curry led the team representing VirnetX. The company also called on Johnny Ward from Ward, Smith & Hill, PLLC, in Longview and attorneys from Parker, Bunt & Ainsworth, P.C., of Tyler. Also representing VirnetX from Caldwell Cassady & Curry were firm principal Justin T. Nemunaitis and firm attorneys Hamad M. Hamad, Warren J. McCarty, Jason S. McManis, Daniel R. Pearson, Christopher S. Stewart, and John F. Summers.
Amyris Inc (NASDAQ:AMRS), jumped 20.37% and closed at $0.770 in the last trading session. The last trading range of the stock ranges between $0.64 and $0.78. The company’s Market capitalization is $179.68 Million with the total Outstanding Shares of 235.02 Million. During the 52-week trading session the minimum price at which share price traded, registered at $0.31 and reached to max level of $2.57. Amyris, Inc. (AMRS), the industrial bioscience company, in partnershipwith the Autodesk BioNano Research Group, recently declared the immediate availability of powerful open source tools for genetic design that leverage Autodesk’s Genetic Constructor, an extensible, open source, cloud CAD tool, and Amyris’s open source Genotype Specification Language (“GSL”), to more rapidly drive biological design and complex DNA construction. Autodesk BioNano Research and Amyris will be showcasing this solution recently at SynBioBeta SF 2016 in San Francisco.